Pharmaceutical - Diabetes, China

Filter

Current filters:

DiabetesChina

Popular Filters

Global insulin market set to reach $32.24 billion in 2019

Global insulin market set to reach $32.24 billion in 2019

28-07-2014

The global insulin market was valued at $19.99 billion in 2012 and is expected to expand at a compound…

AfrezzaChinaDiabetesEli LillyGlobalInsulinLY2605541MannKindMarkets & MarketingMerck & CoMK-1293NN1218Novo NordiskPharmaceutical

China’s Yabao Pharma partners with Eli Lilly to develop diabetes candidate

China’s Yabao Pharma partners with Eli Lilly to develop diabetes candidate

08-07-2014

Chinese drugmaker Yabao Pharmaceutical has entered a strategic partnership with US pharma major Eli Lilly…

ChinaDiabetesEli LillyLicensingPharmaceuticalYabao Pharmaceutical

Diabetes epidemic in China provides lucrative opportunity for anti-diabetic drugs

Diabetes epidemic in China provides lucrative opportunity for anti-diabetic drugs

19-02-2014

The number of people with diabetes in China is set to soar 37% from 118 million to 162 million by 2030,…

ChinaDiabetesMarkets & MarketingPharmaceutical

Back to top